Parkinson’s disease (PD) is the second most common neurodegenerative disease. It is a progressive neurodegenerative disorder, characterized by tremors, slowness of movement, rigidity and problems with balance. These symptoms are believed to be due to the degeneration of the dopaminergic neurons in the substantia nigra. The mechanism of this neurodegeneration in PD remains unclear. (Masino, 2016) Currently, there is only symptomatic treatment, not any treatment for delaying or preventing this neuronal damage in PD.
CLICK HERE TO READ FULL ARTICLE